Controlled release formulation
US6673369B2 · kind B2 · utility
28Cited by
13References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 22, 2002 |
| Grant date | Jan 6, 2004 |
| Priority date | — |
| Expiry date | Jan 26, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2054
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a controlled release pharmaceutical composition comprising amounts ranging from about 0.1 to about 4.5% w/w, of one or more of rate controlling cellulosic ether polymers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.